BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Deals

  Novartis Slams Down $3.9B for This French Cancer Biotech

  Fresh off the heels of its CAR-T approval, Novartis expanded its oncological arsenal with a $3.9B acquisition of Advanced Accelerator Applications.

  October 30, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Startup Riverfield Surgical Robot Laboratory Scores $10M to Challenge Intuitive Surgical

  Riverfield plans to have its device on the Japanese market by 2020.

  October 30, 2017

   · 

  1 min read
• Business

  Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the Quarter Ended 30 September 2017

  The Annual Report is available on the Company’s website at www.gtglabs.com

  October 30, 2017

   · 

  12 min read
• Genetown

  VBI Vaccines Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and Upsized Registered Direct Offering for Aggregate Proceeds of $71.9M

  The pricing for the underwritten public offering was for a total of 16,100,000 common shares.

  October 30, 2017

   · 

  5 min read
• 

  Business

  AstraZeneca Continues to Divest Assets, Takes Stake in Mereo BioPharma With New Deal

  Astra signed a licensing deal with Mereo BioPharma to out license the oral inhibitor of neutrophil elastase to the smaller Mereo.

  October 30, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Deals

  Fosun Pharma to Buy France’s Tridem for $73M

  Fosun Pharma said it would buy Tridem Pharma S.A.S. for $73M, in a move to expand its market share in Europe and Africa.

  October 30, 2017

   · 

  1 min read
• 

  Business

  The Complicated Relationship Between Celgene and President Trump

  On multiple occasions, President Donald Trump has aimed his ire at pharma companies.

  October 30, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Kymera Emerges Out of Stealth Mode With $30M and a Top Team of Drug Hunters

  Kymera Therapeutics launched with a $30M Series A financing which was lead by Atlas Venture.

  October 30, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Job Trends

  This is the Fastest-Growing Private Pharma in the Bay Area

  Want to work for a company having a growth spurt?

  October 30, 2017

   · 

  1 min read
• 

  Deals

  Shire in Talks to Sell 100-Employee Facility in Massachusetts

  As part of consolidation program, Shire is looking to sell a manufacturing facility in Milford, MA that it gained through its 2015 acquisition of Baxalta.

  October 30, 2017

   · 

  2 min read

   · 

  Alex Keown